⌘K

Login Start Free

Home/Filings/4/0001140361-25-045906

4//SEC Filing

Gline Matthew 4

Accession 0001140361-25-045906

CIK 0001635088other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 9:00 PM ET

Size

22.7 KB

Accession

0001140361-25-045906

Insider Transaction Report

Form 4

Period: 2025-12-15

Roivant Sciences Ltd.ROIV

DirectorCEO

Transactions

Exercise/Conversion
Common Shares
2025-12-15$4.06/sh+234,096$950,430→ 17,521,177 total
Sale
Common Shares
2025-12-15$21.68/sh−230,357$4,994,140→ 17,290,820 total
Other
Common Shares
2025-12-15$21.68/sh−3,739$81,062→ 17,287,081 total
Exercise/Conversion
Common Shares
2025-12-15$12.68/sh+1,363,711$17,291,855→ 18,650,792 total
Sale
Common Shares
2025-12-15$21.68/sh−566,116$12,273,395→ 18,084,676 total
Other
Common Shares
2025-12-15$21.68/sh−797,595$17,291,860→ 17,287,081 total
Exercise/Conversion
Common Shares
2025-12-15$12.68/sh+2,272,852$28,819,763→ 19,559,933 total
Sale
Common Shares
2025-12-15$21.68/sh−943,527$20,455,665→ 18,616,406 total
Other
Common Shares
2025-12-15$21.68/sh−1,329,325$28,819,766→ 17,287,081 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-15−234,096→ 0 total
Exercise: $4.06Exp: 2026-04-19→ Common Stock (234,096 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-15−1,363,711→ 0 total
Exercise: $12.68Exp: 2026-03-31→ Common Stock (1,363,711 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-15−2,272,852→ 0 total
Exercise: $12.68Exp: 2026-03-31→ Common Stock (2,272,852 underlying)

Footnotes (3)

[F1]All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.
[F2]Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.
[F3]Award of stock options to purchase Common Shares that is fully vested.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

Roivant Sciences Ltd.

CIK 0001635088

Entity typeother

Related Parties

1

filerCIK 0001750094

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 9:00 PM ET
Size: 22.7 KB

View on SEC.gov